# Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel

> **NCT00402298** · PHASE2 · TERMINATED · sponsor: **Resilient Pharmaceuticals** · enrollment: 5 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Full Dose Midomafetamine HCl
- **DRUG:** Low Dose Midomafetamine HCl

## Key facts

- **NCT ID:** NCT00402298
- **Lead sponsor:** Resilient Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05-27
- **Primary completion:** 2009-03
- **Final completion:** 2010-05-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** This study was terminated after enrolling five subjects due to staff turnover and its effects on quality of data collection.
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402298, "Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00402298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*